243 related articles for article (PubMed ID: 23716988)
1. High-intensity focused ultrasound ablation: an effective bridging therapy for hepatocellular carcinoma patients.
Cheung TT; Fan ST; Chan SC; Chok KS; Chu FS; Jenkins CR; Lo RC; Fung JY; Chan AC; Sharr WW; Tsang SH; Dai WC; Poon RT; Lo CM
World J Gastroenterol; 2013 May; 19(20):3083-9. PubMed ID: 23716988
[TBL] [Abstract][Full Text] [Related]
2. Pilot study of high-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients wait-listed for liver transplantation.
Chok KS; Cheung TT; Lo RC; Chu FS; Tsang SH; Chan AC; Sharr WW; Fung JY; Dai WC; Chan SC; Fan ST; Lo CM
Liver Transpl; 2014 Aug; 20(8):912-21. PubMed ID: 24753206
[TBL] [Abstract][Full Text] [Related]
3. High intensity focused ultrasound, liver disease and bridging therapy.
Mearini L
World J Gastroenterol; 2013 Nov; 19(43):7494-9. PubMed ID: 24282341
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
[TBL] [Abstract][Full Text] [Related]
5. Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas.
Cheung TT; Poon RT; Jenkins CR; Chu FS; Chok KS; Chan AC; Tsang SH; Dai WC; Yau TC; Chan SC; Fan ST; Lo CM
Liver Int; 2014 Jul; 34(6):e136-43. PubMed ID: 24451026
[TBL] [Abstract][Full Text] [Related]
6. Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant.
Wong TC; Lee VH; Law AL; Pang HH; Lam KO; Lau V; Cui TY; Fong AS; Lee SW; Wong EC; Dai JW; Chan AC; Cheung TT; Fung JY; Yeung RM; Luk MY; Leung TW; Lo CM
Hepatology; 2021 Nov; 74(5):2580-2594. PubMed ID: 34091914
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of high-intensity focused ultrasound combined with transarterial chemoembolisation for hepatocellular carcinoma <5 cm: comparison with transarterial chemoembolisation monotherapy--preliminary observations.
Kim J; Chung DJ; Jung SE; Cho SH; Hahn ST; Lee JM
Br J Radiol; 2012 Oct; 85(1018):e940-6. PubMed ID: 22553305
[TBL] [Abstract][Full Text] [Related]
8. Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list.
Fisher RA; Maluf D; Cotterell AH; Stravitz T; Wolfe L; Luketic V; Sterling R; Shiffman M; Posner M
Clin Transplant; 2004 Oct; 18(5):502-12. PubMed ID: 15344951
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma.
Li C; Zhang W; Zhang R; Zhang L; Wu P; Zhang F
Eur J Cancer; 2010 Sep; 46(13):2513-21. PubMed ID: 20663659
[TBL] [Abstract][Full Text] [Related]
10. Survival analysis of high-intensity focused ultrasound ablation in patients with small hepatocellular carcinoma.
Cheung TT; Fan ST; Chu FS; Jenkins CR; Chok KS; Tsang SH; Dai WC; Chan AC; Chan SC; Yau TC; Poon RT; Lo CM
HPB (Oxford); 2013 Aug; 15(8):567-73. PubMed ID: 23458602
[TBL] [Abstract][Full Text] [Related]
11. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.
Li HL; Ji WB; Zhao R; Duan WD; Chen YW; Wang XQ; Yu Q; Luo Y; Dong JH
World J Gastroenterol; 2015 Mar; 21(12):3599-606. PubMed ID: 25834326
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the long-term survival benefits of high intensity focused ultrasound ablation for hepatocellular carcinoma with portal vein tumor thrombus: a single center retrospective study.
Chen X; Ma Y; Zhang J; Yang W; Jin C; Ran L; Zhu H; Bai J; Zhou K
Int J Hyperthermia; 2022; 39(1):1245-1253. PubMed ID: 36137611
[TBL] [Abstract][Full Text] [Related]
13. [Clinical observation on high intensity focused ultrasound combined with transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma].
Wu Y; Li J; Zhang SJ; Zhao YF; Zhao LS; Ma XX; Feng LS; Fan ZJ
Zhonghua Wai Ke Za Zhi; 2012 Aug; 50(8):691-4. PubMed ID: 23157899
[TBL] [Abstract][Full Text] [Related]
14. Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma.
Xing M; Sakaria S; Dhanasekaran R; Parekh S; Spivey J; Knechtle SJ; Zhang D; Kim HS
Cardiovasc Intervent Radiol; 2017 Mar; 40(3):410-420. PubMed ID: 27900445
[TBL] [Abstract][Full Text] [Related]
15. High-intensity focused ultrasound combined with transarterial chemoembolization for unresectable hepatocellular carcinoma: long-term follow-up and clinical analysis.
Jin C; Zhu H; Wang Z; Wu F; Chen W; Li K; Su H; Zhou K; Gong W
Eur J Radiol; 2011 Dec; 80(3):662-9. PubMed ID: 20864286
[TBL] [Abstract][Full Text] [Related]
16. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
Li CX; Wu PH; Fan WJ; Huang JH; Zhang FJ; Zhang L; Gu YK; Zhao M; Gao F; Jiao DC
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(11):754-7. PubMed ID: 19595104
[TBL] [Abstract][Full Text] [Related]
17. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
[TBL] [Abstract][Full Text] [Related]
18. High-intensity focused ultrasound alone or combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with unsuitable indications for hepatectomy and radiofrequency ablation: a phase II clinical trial.
Gu L; Shen Z; Ji L; Ng DM; Du N; He N; Fan X; Yan K; Zheng Z; Chen B; Ma L; Qiu G; Chen P; Zheng J; Yang T
Surg Endosc; 2022 Mar; 36(3):1857-1867. PubMed ID: 33788029
[TBL] [Abstract][Full Text] [Related]
19. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.
Pompili M; Francica G; Ponziani FR; Iezzi R; Avolio AW
World J Gastroenterol; 2013 Nov; 19(43):7515-30. PubMed ID: 24282343
[TBL] [Abstract][Full Text] [Related]
20. Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study.
Ren Y; Cao Y; Ma H; Kan X; Zhou C; Liu J; Shi Q; Feng G; Xiong B; Zheng C
BMC Cancer; 2019 Oct; 19(1):983. PubMed ID: 31640620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
